In Vitro Activity of the New Fluoroketolide Solithromycin (CEM-101) against a Large Collection of Clinical Neisseria gonorrhoeae Isolates and International Reference Strains, Including Those with High-Level Antimicrobial Resistance: Potential Treatment Option for Gonorrhea?

Gonorrhea may become untreatable, and new treatment options are essential. We investigated the in vitro activity of the first fluoroketolide, solithromycin. Clinical Neisseria gonorrhoeae isolates and reference strains (n = 246), including the two extensively drug-resistant strains H041 and F89 and...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Golparian, Daniel, Fernandes, Prabhavathi, Ohnishi, Makoto, Jensen, Jörgen S., Unemo, Magnus
التنسيق: Artigo
اللغة:Inglês
منشور في: American Society for Microbiology 2012
الموضوعات:
Susceptibility
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3346660/
https://ncbi.nlm.nih.gov/pubmed/22354296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00036-12
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة